The former Hospital de la Santa Creu i Sant Pau in the neighborhood of El Guinardó, Barcelona, Catalonia, Spain, is a complex built between 1901 and 1930. It is one of the most prominent works of the Catalan modernisme architect Lluís Domènech i Montaner. The complex was listed as a Conjunto Histórico in 1978.

During the past decade, Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 13 clinical trials were completed, i.e. on average, 68.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia" are "Ovarian Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials) and "Urothelial Carcinoma" (2 trials). Many other conditions were trialed in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia" are "Drug" (26 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (11 trials), "Placebo" (7 trials), "Carboplatin" (6 trials), "Paclitaxel" (5 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia" are 22 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".